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Characterization of FIBCD1 as an Acetyl Group-Binding
Receptor That Binds Chitin1
Anders Schlosser,2* Theresa Thomsen,* Jesper B. Moeller,* Ole Nielsen,† Ida Tornøe,*
Jan Mollenhauer,* Søren K. Moestrup,‡ and Uffe Holmskov*
Chitin is a highly acetylated compound and the second most abundant biopolymer in the world next to cellulose. Vertebrates are
exposed to chitin both through food ingestion and when infected with parasites, and fungi and chitin modulate the immune
response in different directions. We have identified a novel homotetrameric 55-kDa type II transmembrane protein encoded by the
FIBCD1 gene and highly expressed in the gastrointestinal tract. The ectodomain of FIBCD1 is characterized by a coiled-coil
region, a polycationic region and C-terminal fibrinogen-related domain that by disulfide linkage assembles the protein into
tetramers. Functional analysis showed a high-affinity and calcium-dependent binding of acetylated components to the fibrinogen
domain, and a function in endocytosis was demonstrated. Screening for ligands revealed that the FIBCD1 is a high-affinity
receptor for chitin and chitin fragments. FIBCD1 may play an important role in controlling the exposure of intestine to chitin and
chitin fragments, which is of great relevance for the immune defense against parasites and fungi and for immune response
modulation. The Journal of Immunology, 2009, 183: 3800–3809.
C hitin is a linear homopolymer of -1,4-linked N-acetyl-glucosamine, which next to cellulose is the most abun-dant known biopolymer (1). Chitin is an important struc-
tural component in the cell wall of most fungi (2), in the eggshell
of parasitic nematodes (3), and in the exoskeleton of all types of
arthropods, as well as in the cuticle of the epidermis and the tra-
chea and the lining of the gut of many insects (4). Vertebrates are
therefore exposed to chitins through ingested food or when in-
fected with nematodes or fungi.
In plants, chitin and its fragments, chitin oligosaccharides or
N-acetylchitooligosaccharides, are recognized as the typical fungal
pathogen-associated molecular pattern (PAMP)3 that triggers var-
ious defense responses. These include cell surface chitin recogni-
tion receptors like CEBiP (5) and receptor-like kinases like
CERK1 that elicit MARK activation, reactive oxygen species gen-
eration, and gene expression upon activation with chitin (6). Chitin
has recently been identified as a PAMP that modulates the allergic
response in mice (7). Chitin induces an immune response charac-
terized by infiltration of cells that express IL-4 and IL-13 including
Th2 cells, eosinophils and basophiles (7), a response that typically
is seen associated with allergic and parasitic worm immune re-
sponse. Vertebrates lack the ability to produce chitin, but despite
this they do express highly conserved chitinases (8). The acidic
mammalian chitinase (AMCase) is expressed mainly in the sali-
vary glands and by the stomach (9), whereas the chitotriosidase is
expressed by tissue macrophages. Both are endo--1,4-N-acetyl-
glucosaminidases that are believed to be involved in food digestion
and immunity (10). The human chitotriosidase was shown to have
a fungistatic effect (11), and the AMCase has been linked to the
pathophysiology of asthma (12). Soluble mammalian chitin-bind-
ing proteins are known. The C-type lectin RegIIIg (or HIP/PAP)
secreted by Paneth cells is a common pattern recognition molecule
for chitin and peptidoglycan that is induced by symbiotic bacteria
(13). However, a classical chitin receptor has not yet been identi-
fied in vertebrates (14). Here we report the identification a type II
membrane protein expressed apically on enterocytes. The protein
binds acetylated components including chitin and directs ligands
for endocytosis. This receptor is encoded by the FIBCD1 gene and
conserved in all the main vertebrate species.
Materials and Methods
Buffers
TBS (140 mM NaCl, 10 mM Tris-HCl, 0.02% (w/v) NaN2, pH 7.4);
TBS/Tw (TBS containing 0.05% (v/v) Tween 20 (polyoxyethylene sor-
bitan monolaurate; Merck-Schuchardt); PBS (137 mM NaCl, 3 mM KCl,
8 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4); coating buffer (60 mM
Na2CO3, 35 mM NaHCO3, 0.02% (w/v) NaN3, pH 9.6); substrate buffer
(100 mM Tris-HCl, 5 mM MgCl2, 100 mM NaCl, pH 9.5).
Cloning of full-length, ectodomain, and fibrinogen-related
domain of FIBCD1
The various FIBCD1 constructs were generated by PCR using Phusion
DNA polymerase (Finnzymes) and using as template IMAGE clone ID
4811679 (GenBank accession number BC032953; http://www.ncbi.nlm.
nih.gov/GenBank/). Full-length FIBCD1 was generated with the primers:
5-GTCCTGCCGGAAGATGGT-3 and 5-GTCTAGCGGTCCTCCCGG
ACC-3. The V5-His-tagged ectodomain of FIBCD1, encoding aa 54–461,
was generated with the primers 5-CTGAACCACGCCCACGCGCC-3
and 5-GCGGTCCTCCCGGACCGGCC-3; the FIBCD1 ectodomain was
generated with the primers 5-CTGAACCACGCCCACGCGCC-3 and 5-
GTCTAGCGGTCCTCCCGGACC-3. The fibrinogen-related domain of
FIBCD1 was generated with the primers 5-CCCTGATCACGCCACTGG
CTCCCGG (site for BclI digest shown in bold) in and 5-CCCGAATT
CTTAGCGGTCCTCCCGGAC (site for EcoRI digest shown in bold). The
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PCR products were cloned into the expression vectors pSecTag/FRT/V5-
His TOPO TA (FIBCD1 ectodomain), pcDNA/FRT/V5-His TOPO TA
(FIBCD1 full-length), both vectors from Invitrogen), or into the pNT-Bac
vector (the fibrinogen-related domain of FIBCD1), which was kindly do-
nated by Nicole M. Thielens (Institut de Biologie Structurale J.-P. Ebel,
Grenoble, France) using standard molecular biology techniques. The in-
serts were sequenced in their entirety.
Generation of HEK293 and Chinese hamster ovary (CHO) cells
expressing recombinant forms of FIBCD1
To generate cells expressing recombinant forms of the FIBCD1, the Flp-In
system (Invitrogen) was used as described (15) except that HEK293 cells
were selected for stable integration of an FIBCD1-containing construct
using 150 g/ml hygromycin B (Invitrogen).
Expression of the fibrinogen-related domain of FIBCD1 in
insect cells
The pNT-Bac vector containing the fibrinogen-related domain was ex-
pressed in using the baculovirus expression system in sf9 cells essentially
as described by Rossi et al. (16).
Purification of the V5-His-tagged FIBCD1 ectodomain
Purification was performed using a HiTrap Chelating HP (Amersham Phar-
macia Biotech) column as described (15).
SDS-PAGE and Western blotting
Proteins were separated on 4–12% polyacrylamide gradient gels in a dis-
continuous buffer system and blotted onto polyvinylidene difluoride mem-
brane (Immobilon P; Millipore). The membrane was incubated with 0.5
g/ml monoclonal mouse anti-V5 Ab or 0.5 g/ml HG-HYB-12-2 fol-
lowed by alkaline phosphatase-coupled rabbit anti-mouse IgG (Sigma-Al-
drich) diluted 1/2000 in TBS/Tw (500 mM NaCl, 10 mM Tris-HCl, 0.02%
(w/v) NaN2, 0.05% (v/v, pH 7.4) Tween 20). The membrane was washed
and developed as described (15). Western blotting was also performed
using enhanced chemiluminescence (GE Healthcare) for development ac-
cording to the manufacturer’s recommendations. Silver staining was per-
formed essentially as described (17).
Chemical cross-linking of FIBCD1
The V5-His-tagged FIBCD1 ectodomain was cross-linked using bis(sulfo-
succinimidyl)suberate (BS3; Pierce Biotechnology). Briefly, BS3 was
added to the recombinant V5-His-tagged FIBCD1 ectodomain fractions in
a 10- to 320-molar excess and incubated at room temperature for 30 min;
then the reactions stopped by the addition of 0.1 M Tris-HCl buffer, pH 7.4.
The cross-linked samples were reduced and analyzed by SDS-PAGE and
Western blotting.
Deglycosylation of FIBCD1
The presence of N-linked saccharides on the V5-His FIBCD1 ectodomain
that was expressed in HEK293 cells was demonstrated by enzymatic di-
gestion as described (15).
FACS analysis
CHO cells expressing full-length FIBCD1 were incubated with 10 g/ml
anti-FIBCD1 (HG-HYB-12-1) Ab in FACS buffer (PBS, 1% BSA, and
0.05% azide) for 30 min at 4°C, washed twice in FACS buffer, incubated
with FITC-conjugated F(ab)2 goat anti-mouse (DakoCytomation) for 30
min, and then washed three times with FACS buffer before analysis.
Confocal imaging
CHO FIBCD1/CHO cells were seeded at a density of 4  104 cells/well
48 h before experiment. For cell surface staining, cells were incubated with
20 g/ml monoclonal mouse anti-FIBCD1 (HG-HYB-12-1) for 1.5 h at
4°C. After a wash, the cells were incubated with Alexa Fluor 488 F(ab)2
goat anti-mouse IgG (Invitrogen) at 4°C. For internalization experiments,
the cells were incubated with 20 g/ml Alexa Fluor 488-labeled acetylated
BSA at 37°C for 2 h. Finally, the cells were washed twice in PBS and fixed
in 4% paraformaldehyde followed by staining with 4,6-diamidino-2-phe-
nylindole nucleic acid stain (Invitrogen) and mounted using ProLong Gold
antifade reagent (Invitrogen). The fluorescence was visualized with an
Olympus FV1000 microscope.
Production of chicken anti-FIBCD1 Abs
The immunizations and the purification were done by David’s Biotechnol-
ogy. Briefly, 1 hen (White Leghorn) was immunized three times with 30
g of FIBCD1-V5-His ectodomain with a 2-wk interval. The collection of
the first eggs started 43 days after the first immunization. The purification
of IgY polyclonal Abs was performed using a stepwise salting out method.
Production of anti-FIBCD1 mAbs
BALB/c mice were immunized for the production of mAbs against the
FIBCD1 ectodomain. The mice were immunized five times with 5 g of
recombinant FIBCD1 ectodomain with 2 wk between each immunization.
The mice were boosted three times with 10 g of FIBCD1 ectodomain
protein diluted in 200 l of PBS by injection into the dorsal tail vein. B cell
hybridomas were produced by fusion between myeloma cells (American
Type Culture Collection; CRL-2016; Sp2/mIl-6). Abs were purified using
a protein G column on a fast protein liquid chromatography apparatus
(Amersham Pharmacia Biotech). The Ab (HG HG-HYB-12-2) reacts with
the FIBCD1 ectodomain but not with the FIBCD1-FReD when analyzed by
Western blotting. The epitope is therefore located between the TM region
and the FReD domain, excluding cross-reactivity with the ficolins.
Immunohistochemistry
Normal human tissues were obtained from the tissue bank at the Depart-
ment of Pathology, Odense University Hospital (Odense, Denmark). The
tissues were fixed in 4% formalin in PBS for 24 h and then conventionally
dehydrated and embedded in paraffin. A biotin-streptavidin immunoperox-
idase technique was used on paraffin sections. Paraffin sections were pre-
treated in TEG buffer (10 mmol/L Tris, 0.5 mmol/L EGTA, pH 9), in a
microwave oven for three 5-min periods at 650 W. The sections were left
in TEG buffer for 15 min, washed in TBS, preincubated with 2% (w/v)
BSA in TBS for 10 min, and incubated for 30 min with the mouse anti-
human FIBCD1 (HG-HYB-12-2, 0.5 mg/ml) in TBS containing 15% (w/v)
BSA and otherwise processed as described by (18). The specificity of the
immunostaining was verified by replacing the primary Ab with a nonspe-
cific Ab. The local ethical committee in Odense approved the use of the
tissue sections samples (ref. no. VF20050070).
Purification of the nontagged FIBCD1 ectodomain and FIBCD1
fibrinogen-related domain on an N-acetylated immobilized resin
Toyopearl AF-Amino-650M resin (Tosoh; 5 ml) was washed twice with
distilled water and mixed with 4 ml of 0.2 M sodium acetate and 2 ml of
acetic anhydride and then incubated on ice for 30 min. After incubation, 2
ml of acetic anhydride were added to the mixture, and the incubation was
continued for a further 30 min as described (19). The resin was washed four
times with distilled water and 1 M NaOH followed by washing with TBS
(0.5 M NaCl and 5 mM CaCl2) before chromatography. Culture superna-
tant from HEK293 or insect cells was applied to the resin and washed
extensively with TBS (0.5 M NaCl and 5 mM CaCl2). Bound proteins were
eluted in TBS (250 mM sodium acetate).
Characterization of the ligand-binding properties of FIBCD1
An ELISA system was used to evaluate the ability of various acetylated
and nonacetylated compounds to inhibit the binding between FIBCD1
ectodomain and acetylated BSA (Sigma-Aldrich). Microtiter plates
(NUNC Maxisorp) were coated with acetylated BSA (Sigma-Aldrich) or
BSA (Sigma-Aldrich) and blocked with TBS/Tw before being incubated
with FIBCD1 ectodomain samples diluted in TBS/Tw (5 mM CaCl2). The
binding between FIBCD1 and acetylated BSA was also tested in the pres-
ence of 10 mM EDTA, 5 mM MnCl2, or 5 mM MgCl2 instead of CaCl2.
After incubation overnight at 4°C and washing, the wells were incubated
for 2 h at room temperature with chicken anti-FIBCD1 Abs diluted 1/1000
in TBS/Tw (5 mM CaCl2). The plates were washed with TBS/Tw (5 mM
CaCl2) and incubated for 1 h with alkaline phosphatase-labeled anti-
chicken IgY (whole molecule; Sigma-Aldrich) diluted 1/1500 in TBS/Tw
(5 mM CaCl2) followed by washing and developed with 1 mg/ml p-nitro-
phenylphosphate, disodium salt (Boehringer Mannheim) in substrate
buffer. The specificity of the binding to acetylated BSA was assayed by
inhibition with acetylated and nonacetylated compounds including glucose,
-methylglucose, glucosamine, N-acetylglucosamine (GlcNAc), a man-
nose, -methylmannosamine mannosamine, N-acetylmannosamine, galac-
tose, galactosamine, N-acetylgalactosamine, acetylcholine, L-alanine, N-
acetylalanine, sodium acetate, sodium propionate, sodium butyrate, and
N-acetylneuraminic acid (sialic acid) were all from Sigma-Aldrich. Sam-
ples of recombinant FIBCD1 ectodomain (100 ng/ml) were mixed with
inhibitors to give a final inhibitor concentration of 50, 25, 12.5, 6.25, 3.13,
1.56, 0.78, and 0.39 mM in TBS/Tw (5 mM CaCl2). The mixtures were
incubated overnight in the acetylated BSA-coated wells overnight at 4°C
and processed as described above.
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For the PAMPs-binding assay, microtiter plates were coated with LPS
O55:B5 (Sigma-Aldrich), 1 g/ml; LPS 0111:B4 (Sigma-Aldrich), 1 g/
ml; LPS O26:B6 (Sigma-Aldrich), 1 g/ml; lipoteichoic acid (LTA; Invi-
voGen), 10 g/ml; mannan (Sigma-Aldrich), 1 g/ml; soluble peptidogly-
can (InvivoGen), 10 g/ml; and acetylated BSA (Sigma-Aldrich), 1 g/ml,
in coating buffer for 2 h at room temperature and otherwise performed as
described previously except that the fibrinogen domain of FIBCD1 pro-
duced in insect cells was used. As a positive control, surfactant protein D
(SP-D) was added to the plates in parallel with the FReD of FIBCD1. SP-D
bound to LPS, LTA, mannan and soluble peptidoglucan but not to acety-
lated BSA (data not shown).
Pull-down assay
Chitin from crab shells, cellulose, zymosan A, and -1,3-glucan (all from
Sigma-Aldrich) was washed three times in TBS/Tw (5 mM CaCl2) and
pelleted. Twenty micrograms of the fibrinogen-related domain of FIBCD1
were added to 2 mg of each carbohydrate in a total volume of 500 l of
TBS/Tw (5 mM CaCl2). For the inhibition experiment, pelleted chitin was
incubated with 20 g of FIBCD1 in TBS/Tw (10 mM EDTA) or TBS/Tw
(250 mM sodium acetate). Twenty micrograms of wheat germ agglutinin
(WGA) were added to 2 mg of chitin as a positive control. Twenty micro-
grams of BSA were added to chitin as a negative control. Twenty micro-
grams of FIBCD1 without chitin as a blank control. After overnight incu-
bation at 4°C, the pelleted carbohydrates were washed three times in
TBS/Tw (5 mM CaCl2). Bound protein was eluted by boiling the pelleted
carbohydrates in SDS-PAGE buffer and resolved by SDS-PAGE through
4–17% polyacrylamide gels followed by Coomassie staining.
Endocytosis of 125I-labeled acetylated BSA
Endocytosis experiments were performed with FIBCD1-expressing Flp-In
CHO cells or nontransfected Flp-In CHO cells grown to confluence in
24-well plates essentially as described (20). In brief, acetylated BSA was
labeled with 125I using the chloramine-T method, and triplicates of cells
were incubated in Ham’s F-12 medium supplemented with 1% BSA con-
taining 4000 cpm of 125I-labeled acetylated BSA for various time intervals
at 37°C.
Alexa Fluor 488 labeling of acetylated BSA
Lyophilized powder of acetylated BSA was dissolved in PBS, pH 7.4, to a
concentration of 10 mg/ml, and thiols for coupling were generated by re-
ducing cystine disulfides with the reducing agent tris(2-carboxyethyl)phos-
phine (Sigma-Aldrich) at a concentration of 10 mM. At a concentration of
2.5 mg/ml, acetylated BSA was incubated with Alexa Fluor 488 C5 ma-
leimide (Invitrogen) in a 1:10 molar ratio for 2 h at room temperature
followed by extensive dialysis against PBS to remove free dye.
Sequence analysis
DNA sequence analysis, alignments, and amino acid sequence prediction
were done with Lasergene software (DNAStar). Multiple sequence align-
ments were conducted using a ClustalW algorithm (http://www.ebi.ac.uk/
clustalw). Membrane topology and putative membrane-spanning domains
were determined by Hidden Markov Model analysis software
(http://www.cbs.dtu.dk/services/TMHMM/).
Results
Identification and predicted domain organization of a potential
acetyl group-binding protein
We searched the National Center for Biotechnology Information
Human Expressed Sequence Tag clone database using the L-fico-
lin cDNA sequence in a homology search for possible new acetyl
group-binding molecules with membrane topology. This approach
revealed a cDNA clone of 3190 bp (GenBank accession number
BC032953; http://www.ncbi.nlm.nih.gov/GenBank/) that showed
high homology to L-ficolin, M-ficolin, and the tachylectin 5 group.
The gene, named fibrinogen C domain-containing protein 1
(FIBCD1), maps to chromosome 9q34.12–q34.13 and is encoded
by seven exons spanning 36 kb of DNA (Fig. 1). The FIBCD1
cDNA has an open reading frame of 1383 bp encoding a 461-aa
protein that predicts a type II transmembrane protein composed of
a 31-aa cytoplasmic tail, a 23-aa transmembrane helix, and a
408-aa ectodomain. The cytoplasmic tail includes a threonine at
position 8 and a serine at position 27 that potentially can be phos-
phorylated (www.cbs.dtu.dk/services/NetPhos/). Several stretches
of the sequence 110–208 located between the transmembrane seg-
ment and a fibrinogen-related domain (FReD) display homology to
the coiled-coil regions of myocin and the angiopoietins and are
predicted to form coiled-coil structures (COILS version 2.2) (21).
A polycationic region containing four repeats with two arginines
arranged symmetrically around a proline is found in front of the
C-terminal FReD. The FReD of FIBCD1 is the part that shows
homology to the innate immunity proteins L-ficolin, M-ficolin, and
tachylectin 5A (TL5A), and these proteins bind acetyl groups
through their FReDs. Database analysis revealed that FIBCD1 is
highly conserved in vertebrates from mammals to birds, amphib-
ians, and fish (Fig. 2). Insects and worms also express membrane-
bound FReDs, but in these molecules the conserved residues in-
volved in acetyl group binding are lost.
Structural characterization of FIBCD1
We expressed the ectodomain of FIBCD1 as a secreted protein in
the human cell line HEK293 to obtain insight into the structural
organization of the receptor. The purified protein migrates corre-
sponding to a molecular mass of 55 kDa in the reduced state and
250 kDa in the unreduced state on SDS-PAGE (Fig. 3A). This
demonstrates that FIBCD1 is assembled as a disulfide-linked ho-
mopolymeric structure. One cysteine is located in the region of
potential coiled coils and two cysteines are located at the bound-
aries, those being involved in the interchain disulfide bridge for-
mation is yet unknown (Fig. 1). We then did chemical cross-link-
ing at various concentrations of BS3 of FIBCD1 ectodomain. Four
distinct bands were observed corresponding to monomeric,
dimeric, trimeric, and tetrameric structures, when analyzed in the
reduced state by SDS-PAGE (Fig. 3B). Treatment with N-gly-
canase reduced the molecular mass of the ectodomain of the re-
ceptor with 2–3 kDa (Fig. 3C). FIBCD1 is predicted to be a mem-
brane protein with type II topology. FACS analysis (Fig. 3D) and
immunofluorescence confocal microscopy analysis (Fig. 3E) of
CHO cells transfected with the full-length FIBCD1 cDNA showed
a cell surface localization. Taken together, we conclude that
FIBCD1 is a glycoprotein that forms disulfide-linked homotetram-
ers in the plasma membrane. A model of the FIBCD1 is shown in
Fig. 3F.
Immunohistochemical localization of FIBCD1
Immunohistochemical analysis of human tissues showed high ex-
pression of FIBCD1 in small and large intestine epithelial cells
with a highly polarized localization to the apical surface corre-
sponding to the brush border (Fig. 4, A–E) and in the ducts of the
salivary glands (Fig. 4F). Weak or no reactivity was observed in
stomach epithelial cells, in respiratory cells, or in urogenital epi-
thelial cells (not shown). As a positive control, strong immunore-
activity was found in HEK293 transfected with FIBCD1 cDNA,
whereas no reaction was found in nontransfected HEK293 cells
(Fig. 4, G and H). The specificity of the mAb used for immuno-
histochemical analysis was further analyzed using Triton X-100
lysates of HEK293 and HEK293 transfected with FIBCD1 cDNA
for Western blotting (Fig. 5).
The relative levels of the FIBCD1 mRNA were determined in
22 different human tissues by real time PCR (data not show). The
mRNA was measured in virtually all tissues analyzed. No corre-
lation was found between the mRNA levels measured by RT-PCR
and the immunohistochemistry.
FIBCD1 is a calcium-dependent acetyl group-binding molecule
The alignment of the human ficolins with TL5A and FIBCD1 re-
veals that some but not all of the residues of the TL5A and L- and
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FIGURE 1. The chromosome localization, genomic organization of FIBCD1, and the mRNA transcripts and deduced amino acid sequence of FIBCD1.
The initiation methionine is marked as 1. , potential glycosylation site. The transcription initiation site, stop codon, and polyadenylation site are boxed.
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M-ficolin comprising the acetyl group-binding site are conserved
in the FIBCD1 (Fig. 6). Accordingly, we attempted to purify the
ectodomain of FIBCD1 by affinity chromatography on acetylated
Toyopearls (19). Fig. 7A shows a Western blot of the culture su-
pernatant from HEK293 cells expressing FIBCD1 ectodomain.
Fig. 7B shows the acetate elution profile from the acetylated Toyo-
pearls, and a silver-stained SDS-PAGE of the purified FIBCD1
ectodomain is shown in Fig. 7C. This shows that FIBCD1, like
TL5A, L-ficolin, and M-ficolin, can be affinity purified using an
acetate-coupled matrix.
We next tested the ability of FIBCD1 to bind acetylated mole-
cules by an ELISA-based approach. The purified FIBCD1 ectodo-
main-bound acetylated BSA-coated microtiter plates in the pres-
ence of calcium. The binding was saturable and abolished by
chelating of divalent ions (Fig. 7D). The binding between FIBCD1
and acetylated BSA was tested in presence of increasing concen-
trations of CaCl2 (Fig. 7E) and CaCl2 was substituted by other
divalent cations (Fig. 7F). These experiments show that optimal
binding to acetylated BSA is achieved at a calcium concentration
of 0.6 mM and that manganese could substitute for calcium
whereas magnesium did not.
The ligand selectivity of FIBCD1 was investigated by inhibiting
the binding of FIBCD1 to acetylated BSA-coated microtiter plates
(Fig. 7G). The inhibition experiments demonstrated that N-acety-
lated carbohydrates or amino acids, but not their corresponding
nonacetylated counterparts, could inhibit the binding. Further-
more, one of the simplest compounds containing the acetyl group,
sodium acetate, strongly inhibited the binding even at millimolar
levels, whereas sodium propionate and sodium butyrate did not
inhibit at a concentration of 50 mM. Other acetylated compounds
like acetylcholine could also inhibit the binding of FIBCD1 to
acetylated BSA (Table I).
FIBCD1 binds to chitin but not to other tested PAMPs
Different PAMPs were considered to be potential ligands for the
FIBCD1-encoded protein. LTA and -1,3-glucan are known li-
gands for L-ficolin (22) and TL5A recognize the O-Ag of LPS
(23). Peptidoglycan consists of repeating GlcNAc and MurNac
residues cross-linked by short peptides, a structure that is very
similar to the (GlcNAc)n structure of chitin. We saw no binding to
LPS, LTA, mannan, or peptidoglycan (Fig. 8, A and B). However,
FIBCD1 showed clear chitin binding activity in pull-down assays
FIGURE 2. Alignment of the known FIBCD1 protein sequences using CRUSTAL V from the DNAStar package.
FIGURE 3. Structure of FIBCD1. A, SDS-PAGE and silver staining of
purified V5-His-tagged FIBCD1 ectodomain in the reduced (lane 1) and
unreduced state (lane 2). B, Western blotting of the V5-His-tagged
FIBCD1 ectodomain after cross-linking with increasing concentration of
the cross-linker BS3 in the reduced state. C, The V5-His-tagged FIBCD1
ectodomain with and without enzymatic digest of N-linked glycans. D and
E, Type II membrane topology of FIBCD1 analyzed by FACS and confocal
microscopy analysis of CHO-FIBCD1/CHO cells using monoclonal mouse
anti-FIBCD1 (HG-HYB-12-1). F, A model of the FIBCD1.
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where WGA was used as positive control (Fig. 8C). As for the
binding to acetylated BSA, the binding was calcium dependent and
could be inhibited by sodium acetate (Fig. 8D). Parallel pull-down
experiments using equivalent masses of zymosan, cellulose (the
nonacetylated counterpart to chitin), or -1,3-glucan showed no
binding. Together, these results imply that FIBCD1 has specific
preference for chitin.
Uptake of 125I-labeled acetylated BSA in FIBCD1-expressing
CHO cells
FIBCD1-mediated endocytosis of 125I-labeled acetylated BSA was
studied in CHO cells transfected with a FIBCD1 expression vector.
Fig. 9 shows the time course of cell-associated radioactivity and
TCA-soluble radioactivity (as a measurement of ligand degrada-
tion) in the medium (Fig. 9, A and B). The cell-associated radio-
activity reached a plateau after 1 h of incubation, at about the same
time as the TCA-soluble radioactivity increased significantly in the
medium. The degradation was strongly inhibited by the weak base
chloroquine and the proteinase inhibitor leupeptin (Fig. 9C), which
both inhibit lysosomal proteolysis. The uptake was mediated by
FIBCD1 in that no uptake was seen in nontransfected CHO cells
(Fig. 9A). Furthermore, the uptake and degradation of I125 labeled
acetylated BSA were inhibited by 10 mM GlcNAc, by unlabeled
acetylated BSA, and by the mAb HG-HYB-12-1, which specifi-
cally inhibits the binding between acetylated BSA and FIBCD1
(Fig. 9D). Finally, we show that CHO cells expressing recombi-
nant FIBCD1 mediate uptake of Alexa Fluor 488-labeled acety-
lated BSA (Fig. 9E), whereas no uptake was seen in nontransfected
CHO cells (Fig. 9F).
Discussion
Our in silico screen followed up by functional analysis identified
the FIBCD1 as a receptor that binds acetylated structures including
chitin. The fibrinogen domain was originally identified as inde-
pendent folded globular domains in the C-terminal region of both
the - and -chain of fibrinogen. Domains homologous to the fi-
brinogen domain have since been identified and characterized in a
growing number of nonfibrinogen proteins, where the domains are
FIGURE 4. Localization of the
FIBCD1 in human tissues. Formalde-
hyde-fixed paraffin-embedded cells or
tissues were incubated with the mAb
HG-HYB-12-2 directed against the
FIBCD1 and developed with biotin-
labeled goat anti-mouse Ig, HRP-cou-
pled streptavidin and substrate. Sec-
tions were counterstained with
Mayer’s hematoxylin. A–C, Duode-
num; D and E, colon; F, salivary
gland; G and H, HEK293 with and
without transfection of the FIBCD1
ectodomain cDNA. Original magnifi-
cation, 200 (A and D); 400 (E, G,
and H), and 600 (B, C, and E).
FIGURE 5. Western blot of Triton X-100 lysates from HEK293 (lanes
1 and 2) and HEK293 transfected with FIBCD1 ectodomain cDNA (lanes
3 and 4) in the unreduced state (lanes 1 and 3) or reduced state (lanes 2 and
4). The Western blot was developed using monoclonal anti-FIBCD1 Ab
(HG-HYB-12-2).
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referred to as fibrinogen-related domains or fibrinogen-like recog-
nition domains (FReDs) (24). Proteins that include FReDs have
been identified in a large number of distantly related species in-
cluding vertebrates, echinoderms, mollusks, and insects. In verte-
brates, fibrinogen is involved in platelet aggregation and fibrin clot
formation. The blood coagulation pathways of invertebrates, when
present, are not homologous to the fibrinogen-mediated coagula-
tion pathway of vertebrates (25), and the FReDs must have
evolved for other functions. Many of the FReDs identified in in-
vertebrates show lectin activity (26), suggesting that the primordial
FReDs function may have been innate immune recognition. Oth-
ers, like scabrous identified in Drosophila megalogaster, interact
with Notch and play a role in embryogenesis. It is therefore likely,
that FReDs have evolved to take part in diverse functions includ-
ing innate immunity, embryonic development, and coagulation
(27–29).
Sequence comparison indicated a potential functional relation-
ship of FIBCD1 to TL5A and to L- and M-ficolin. We found that
FIBCD1 selectively and Ca2 dependently bind acetylated
monosaccharide and other acetylated components but not their
nonacetylated counterparts. This suggested that the primary li-
gand-binding site in FIBCD1 resides in the FReD and that
FIGURE 6. Sequence alignment of the fibrinogen-related domains of FIBCD1, TL5A, and the human ficolins. Numbers on top and below refer to
L-ficolin and TL5A sequences, respectively. The binding site residues are green (S1), bold red (S2), black (S3), and bold orange (S4). Residues involved
in Ca2 binding in L-, M-, and H-ficolin and TL5A are shown in yellow (22).
FIGURE 7. The ectodomain of FIBCD1 is an acetyl group-binding mol-
ecule. A, SDS-PAGE and Western blotting analysis of culture supernatant
from HEK293 cells expressing the FIBCD1 ectodomain in the nonreduced
(lane 1) and reduced (lane 2) state developed with the monoclonal mouse
anti-FIBCD1 (HG-HYB-12-2). B, Culture supernatant from HEK293 cells ex-
pressing the ectodomain of FIBCD1 was run onto a column with N-acetyl-
Toyopearls in TBS containing 5 mM CaCl2 followed by a wash in the same
buffer and elution with buffer containing 250 mM sodium acetate. C, Silver-
stained SDS-PAGE of fractions from B in the reduced and unreduced state. D,
Microtiter plates were coated with BSA or acetylated BSA and increasing amounts
of the ectodomain of FIBCD1 was added in the presence of 5 mM CaCl2 or 10
mM EDTA. E, Microtiter plates were coated with acetylated BSA and 60 ng/ml
and FIBCD1 ectodomain was added in the presence of 0–1 mM CaCl2. F, Mi-
crotiter plates were coated with acetylated BSA, and increasing amounts of
FIBCD1-encoded ectodomain were added in the presence of 5 mM CaCl2, 5 mM
MgCl2, or 5 mM MnCl2. G, Microtiter plates were coated with acetylated BSA,
and 60 ng/ml FIBCD1 ectodomain were added in the presence of increasing con-
centrations of N-acetylmannosamine (ManNAc), acetate, or proprionate.
Table I. I50 values of the binding between the chitin receptor and
acetylated BSAa
Inhibitor I50 (mM) I50 Relative
Sialic acid 2 1
Glucose NI
Glucosamine NI
N-Acetylglucosamine 4 0.5
Mannose NI
Mannosamine NI
N-Acetylmannosamine 2 1
Galactose NI
Galactosamine NI
N-Acetylgalactosamine 5 0.4
Alanine NI
N-Acetylalanine 4 0.5
Acetylcholine 10 0.2
Acetate 3 0.7
Butyrate NI
Propionate NI
a I50 calculated from inhibition curves as shown in Fig. 5G. The relative inhibitor
potential was determined by dividing the I50 of the best inhibitor with the I50 of the
desired compound. NI, not inhibitory (i.e., resulting in 50% inhibition at 50 mM).
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FIBCD1, like TL5A and the L- and M-ficolins, is a pattern rec-
ognition receptor that preferentially binds simple acetylated com-
ponents (30, 31). The acetyl group specificity of TL5A was ex-
plained by the crystal structure of TL5A in complex with GlcNAc
(32). Four aromatic site chains, Tyr210, Tyr236, Tyr248, and His220,
forms a funnel, with the methyl side chain of Ala237 at its base.
The sugar methyl group benefits from the hydrophobic environ-
ment and lies in the middle of the funnel, surrounded by the aro-
matic site chains and in close van der Walls contact with the site
chain methyl group of Ala237. An unusual cis-peptide bond be-
tween Arg218 and Cys219 generates a sharp turn and allows the
backbone NH group of the Cys to form a tight hydrogen bond with
the carbonyl oxygen of the ligand acetamido group. The same
cis-peptide bond was found in L-ficolin (22) between Asn244 and
Cys245, and in M-ficolin between Asp253 and Cys254 (22), and we
speculate that the same can be the case for the homologous Asn413
and Cys414 residues in FIBCD1.
The hydrophobic funnel containing the sugar methyl group is
essentially conserved in FIBCD1, the main difference being Tyr248
substituted with a tryptophan (Fig. 6). The homolog-binding site
(designated S1 binding site) is also present in L- and M-ficolin. In
M-ficolin, acetylated carbohydrates occupy the binding site, but
although L-ficolin binds acetylated compounds with high affinity,
no ligands were found in the hydrophobic funnel when analyzing
the crystal structure of L-ficolin (22). Site-directed mutagenesis
analysis of the FReD of FIBCD1 changing H415G or A432V ab-
rogate N-acetylated carbohydrate binding to FIBCD1 indication
that the funnel indeed is occupied in FIBCD1 (T. Thomsen and U.
Holmskov, manuscript in preparation). We speculate that phenyl-
alanine at position 262 in L-ficolin could be an essential residue for
preventing binding of L-ficolin to N-acetylated carbohydrates in
the pocket, as this is the only residue that is not conserved between
L-ficolin and M-ficolin, TL5A, or FIBCD1.
The structure of L-ficolin revealed three additional binding sites
(S2–S4), and the acetylated ligands were found to bind to site S3
(22). The acetyl moiety of these ligands bound to the backbone
nitrogen of L-ficolin Asp133, a residue not conserved in either
TL5A or FIBCD1. Galactose bound to S2 and the first three of four
glucose residues of -1,3-glucan, a well-known ligand for L-fico-
lin, were spanning the binding sites S3 and S4 (22, 33). These
binding sites were not conserved in FIBCD1, and no binding was
observed between these ligands and FIBCD1. Furthermore, we
could not show any binding to LPS or to LTA which are known to
be ligands for TL5A (34) and L-ficolin, respectively (35).
Pattern recognition receptors often enhance their selectivity for
ligands by oligomerization. The disulphide-linked ectodomain of
FIBCD1 were shown to form tetramers using cross-linking at dif-
ferent concentrations of BS3, indicating that FIBCD1 forms ho-
motetramers in the plasma membrane. This arrangement of four
FReD domains at a predetermined distance provides a platform for
high-affinity recognition of ligands carrying appropriately spaced
acetylated structures. The formation of tetramers contrasts with
others multimeric FReD molecules like the ficolins that form tri-
mers stabilized by extended collagen regions but it is in line with
FIGURE 8. The FIBCD1 fibrinogen-related domain (FReD) binds
chitin, but not to LTA, peptidoglycan, LPS, zymosan, or mannan. A, Mi-
crotiter plates were coated with LPS 055, LPS 0111 LPS 026 or acetylated
BSA. B, Microtiter plates were coated with LTA, mannan, peptidoglycan,
or acetylated BSA, and increasing concentrations of FIBCD1 were added.
C, Pull-down assays in which 20 g of the FReD of FIBCD1 or as a
positive control 20 g of WGA were added to 2 mg of insoluble chitin,
cellulose, zymosan or -1,3-glucan. D, Pull-down assays in which 20 g
of the FReD of FIBCD1 were added to 2 mg of insoluble chitin in the
presence of 5 mM calcium, 100 mM sodium acetate, or 10 mM EDTA.
BSA was used as a negative control. Pellet fractions were analyzed by
SDS-PAGE and Coomassie blue staining. FIGURE 9. FIBCD1-mediated endocytosis of 125I-labeled acetylated
BSA. A, time course for cell-asscociated (f) and degraded () 125I-labeled
acetylated BSA in CHO/CHO-chitin receptor cells. Confluent cell layers
were incubated with 125I-labeled acetylated BSA at 37°C for various time
intervals. Degradation was measured, as the cell-mediated increase of
TCA-soluble radioactivity in the growth medium and cell-associated was
determined by counting the radioactivity of the cell lysate. A, CHO cells;
B, CHO-FIBCD1 cells. C, Effect of the lysosomal inhibitors chloroquine
and leupeptin (both 100 M) on endocytosis of acetylated BSA. Values are
mean  SD of triplicate samples. D, Inhibition of 125I-labeled acetylated
BSA uptake. E and F, Fluorescence microscopy of CHO and CHO-
FIBCD1 after incubation with Alexa Fluor 488-labeled acetylated BSA.
Glc, Glucose.
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TL5A that forms tetramers in solution (19). We thus hypothesize
that the three-dimensional arrangement of the FReD-domain rep-
resents one of the reasons for the chitin selectivity of FIBCD1.
In search for a natural ligand for the receptor, we performed a
pull-down experiment and found that the receptor specifically bind
to chitin. The binding was Ca2 dependent and could be inhibited
by sodium acetate, suggesting that the binding takes place via the
S1 binding site. Chitin has been shown to recruit and activate
innate immune cells and induce cytokine and chemokine produc-
tion via a variety of cell surface receptors (37). Phagocytosis of
chitin particles has previously been shown to induce the produc-
tion of IL-12, TNF-, and INF- in mouse spleen cell cultures; and
this cytokine production was abrogated by preincubation with sol-
uble mannan, but the actual receptor that mediated the response
was not identified (38). The same group showed that oral admin-
istration of chitin down-regulates serum IgE levels and lung eo-
sinophilia in a ragweed-immunized allergic mouse model, suggest-
ing that chitin administered this way is a Th1 adjuvant, that inhibits
the allergic response (39). Chitin administered directly to the lung
has the opposite effect. In this case, chitin contributed to the de-
velopment of the allergic inflammatory response by inducing the
accumulation of IL-4 expression innate immune cells including
eosinophils and basophils; this response was unaffected by the ab-
sence of MyD88 signaling but was inhibited by treatment with
AMCase (7). Recently, De Silva et al. (37) demonstrated in vitro
activation of macrophages and in vivo induction of lung inflam-
mation measured as IL-17A production. The in vitro response was
dependent on chitin size and time of incubation and both in vivo
and in vitro responses were TLR-2 and MyD88 dependent. It
has been shown that TLR-2/dectin-1 (-glucan) and TLR-4/
mannose receptor (O-linked and N-linked mannosyl residues)
pathways are involved in the mucosal inflammatory response to
Candida albicans (40, 41). Future studies will show whether
FIBCD1 acts as a coreceptor for TLR-2 in the response to chitin
fragments. Thus far, the soluble C-type lectin RegIIIg is the
only known pattern recognition molecule in vertebrates that has
been shown to bind chitin (13).
We here demonstrate that FIBCD1 facilitates the endocytosis of
acetylated components using 125I-labeled acetylated BSA as a
model molecule. We found high uptake of 125I-labeled N-acetyl-
BSA in FIBCD1-transfected CHO cells, whereas no uptake was
seen in nontransfected CHO cells. The uptake was, after a lag
phase, followed by the appearance of 125I-labeled degradations
products in the medium. Degradation was inhibited by chloroqine
and leupeptin, which both are known inhibitors of lysosomal pro-
teolysis. In accordance with a receptor-mediated endocytosis,
50% of the surface-bound radioactivity was present as TCA-
soluble radioactivity after 1–2 h. FIBCD1-dependent binding and
uptake of Alexa Fluor 488-labeled acetylated BSA to CHO cells
further supported a role of FIBCD1 in uptake of acetylated
components.
We have discovered FIBCD1 as the first membrane-bound
FReD molecule in vertebrates and the first pattern recognition re-
ceptor that bind chitin and directs acetylated components for deg-
radation in the endosome. Its prevalence at the apical part of small
intestinal epithelial cells specifically point to a role in innate im-
munity and/or homeostasis in the intestine.
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